Hofseth Biocare inks research deal with Stanford University

The study will take two years.

Hofseth BioCare CEO Roger Hofseth. — Hofseth BioCare CEO Roger Hofseth.Photo: Morten Hjertø

Demi Korban

Published 11 May 2020, 10:30Updated 11 May 2020, 11:27

biotech Research Hofseth Biocare Roger Hofseth